A Fennec Pharmaceuticals drug that prevents hearing loss in children receiving cancer treatment is now approved. The regulatory decision comes more than two years later than expected, but the company now claims its drug, Pedmark, is the first and only FDA-approved therapy for reducing the risk of chemotherapy-induced hearing loss in pediatric cancer patients.
San Francisco-based Blumio and Saint Paul, Minnesota-based NxGenPort tied for the top prize in the Remote Patient Monitoring and Smart Devices track of INVEST Pitch Perfect, the startup competition integral to MedCity News' INVEST conference. Here is an in-depth look at each company.
BeyondSpring Pharmaceuticals’ corporate reorganization comes about six weeks after the FDA rejected the biotech’s drug for a complication experienced by cancer patients. The company still plans to develop the drug for that application and others, but it added that layoffs are needed to reduce expenses.
BeyondSpring Pharmaceuticals said the FDA wants another clinical trial to demonstrate patient benefit for its drug, a small molecule developed to treat a dangerous and life-threatening complication of chemotherapy. Shares of the biotech plunged more than 60% after the FDA’s complete response letter was announced.
Athenex’s bid to offer an oral version of an intravenous chemotherapy has stalled after the FDA rejected the drug. Among the remedies proposed by the regulator is another Phase 3 study.
The drug offers greater convenience and efficacy than the old chemotherapy combination, but its high cost and first impressions among doctors may explain why Jazz had to lower its sales guidance.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The study can assure clinicians that Sandoz's Zarxio works just as well in febrile neutropenia as originator Amgen's Neupogen, author says in interview.
The American Society of Clinical Oncology is recommending that all patients age 65 and older receive a geriatric assessment when considering or undergoing chemotherapy.
While it's hard to get excited about a modified chemotherapy drug in an era of personalized medicine, checkpoint inhibitors, and CAR-T immunotherapies, Modra Pharmaceuticals' modified taxane drugs could make a sizeable impact in the field.
Symberix just raised $500,000 in SBIR grants to build out its microbiome-based drugs.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
It takes several months and several tests to determine whether chemotherapy is working. San Diego startup Biological Dynamics just raised $22.8 million for its simple, inexpensive blood test that can tell whether a patient is responding to a cancer treatment.
Billionaire investor Patrick Soon-Shiong buys the rights to a next-gen Abraxane from Sorrento Therapeutics - building on the drug that launched his own fortune.
After 17-year-old Cassandra in Connecticut was recently diagnosed with Hodgkin lymphoma, cancer of the lymph system, she decided to refuse chemotherapy treatment against her doctors recommendations. But now she’s being forced to undergo treatment against her will. Doctors reported Cassandra’s single mother Jackie Fortin for neglect, which led to a court giving the state Department […]
Chemotherapy treatments can be especially traumatic for kids and young people. There are needles, exhausting procedures, emotional pain that comes from isolation and anxiety, all of which could eventually result in post-traumatic stress disorder (PTSD). But with the new Infusionarium at the Children’s Hospital of Orange County, the treatment could be less abrasive (and actually be […]
In 2012, Emily Helck was diagnosed with breast cancer. Watch the viral video above to see the progression of her cancer treatment. These photos are true breast cancer awareness, and they aren’t wrapped up in pink ribbon. “Cancer is embarrassing,” she told ABC News. “As a friend or co-worker or acquaintance, it’s hard to know […]
